Article ID: 8a986ce4ab6ca746c6390c0730880cd31d104a3ad1ebe0ca66c11c7beb3465cb
Source ID: secondary:businessinsurance.com
Published At: -
Extraction Method: bs4_heuristic
Body Text
Boston Scientific says unlikely to meet sales, forecast after cyberattack - Business Insurance Skip to content Register for free Search Search Log In Risk Management Cyber Risks Pricing Trends Mergers & Acquisitions Technology Sponsored Content WSIA RISKWORLD Workers Comp & Safety Workers Comp Cost Control Pain Management Workplace Safety International EMEA Asia-Pacific Latin America People Events BI Intelligence Top 100 Agents & Brokers Best Places to Work 2026 Lists Directories Insurance Pricing BI Stock Index Magazine Current Issue Past Issues Subscribe Women to Watch ALL INsurance Resources Risk Perspectives Sponsored Content Webinars White Papers Risk Management Cyber Risks Pricing Trends Mergers & Acquisitions Technology Sponsored Content WSIA RISKWORLD Workers Comp & Safety Workers Comp Cost Control Pain Management Workplace Safety International EMEA Asia-Pacific Latin America People Events BI Intelligence Top 100 Agents & Brokers Best Places to Work 2026 Lists Directories Insurance Pricing BI Stock Index Magazine Current Issue Past Issues Subscribe Women to Watch ALL INsurance Resources Risk Perspectives Sponsored Content Webinars White Papers Risk Management Cyber Risks Pricing Trends Mergers & Acquisitions Technology Sponsored Content WSIA RISKWORLD Workers Comp & Safety Workers Comp Cost Control Pain Management Workplace Safety International EMEA Asia-Pacific Latin America People Events BI Intelligence Top 100 Agents & Brokers Best Places to Work 2026 Lists Directories Insurance Pricing BI Stock Index Magazine Current Issue Past Issues Subscribe Women to Watch ALL INsurance Resources Risk Perspectives Sponsored Content Webinars White Papers Risk Management Cyber Risks Pricing Trends Mergers & Acquisitions Technology Sponsored Content WSIA RISKWORLD Workers Comp & Safety Workers Comp Cost Control Pain Management Workplace Safety International EMEA Asia-Pacific Latin America People Events BI Intelligence Top 100 Agents & Brokers Best Places to Work 2026 Lists Directories Insurance Pricing BI Stock Index Magazine Current Issue Past Issues Subscribe Women to Watch ALL INsurance Resources Risk Perspectives Sponsored Content Webinars White Papers Boston Scientific says unlikely to meet sales, forecast after cyberattack Cyber Risks , Emerging Risks , Technology Sep 8, 2026 (Reuters) — Boston Scientific said on Tuesday it no longer expects to meet its previously issued third-quarter and full-year 2026 sales and adjusted profit forecast s, after a cybersecurity incident disrupted the medical device maker’s global operations. An unauthorized activity on some of its information technology systems, first identified on August 25, caused a network outage that disrupted manufacturing and the processing and shipment of customer orders, the company said in a regulatory filing. Stifel analyst Rick Wise said investors increasingly view 2026 as a “lost year” for Boston Scientific and are likely to focus more on the company’s prospects for 2027. Shares of the company were down 2.3% in morning trading. In July, Boston Scientific had forecast 2026 adjusted earnings of $3.28 to $3.32 per share and sales growth of 5.5% to 6.5% on a reported basis. For the third quarter, it had projected adjusted earnings of 80 cents to 82 cents per share. It expects to recover a portion of the affected revenue as it ramps up operations and works through backlogs, but said the full financial impact remains uncertain. The incident is the latest in a series of cyberattacks on the healthcare sector, with medical device makers Abbott Laboratories, Stryker and Medtronic and drugmaker Novo Nordisk among those recently hit. In an update on Saturday, Boston Scientific said that the incident’s effects were limited to select internal infrastructure and that product quality analyses found no impairment beyond disruptions to new activations of its cardiac device remote-monitoring platform. J.P. Morgan analyst Robbie Marcus said the cyberattack clouds visibility into Boston Scientific ‘s underlying business trends, delaying investors’ ability to assess growth and competitive dynamics in key franchises, including electrophysiology and heart device Watchman. The company said major distribution centers are now processing and shipping orders at or above normal levels, sterilization facilities are operational, and manufacturing has resumed across most facilities globally. Boston Scientific plans to provide an update d outlook when it reports third-quarter results on October 28. Related News Aspen’s Dunleavy to take over at Conduit September 8, 2026 Markel chairman to retire, succeeded by CEO September 8, 2026 Cincinnati Insurance found in bad faith over pandemic-era claim denials September 8, 2026 Vantage names Yves Charbonneau chief risk officer September 8, 2026 Indiana court upholds benefits for worker who fainted while driving September 8, 2026 Compre takes on Lloyd’s reserves in retrospective reinsurance deal September 8, 2026 China proposes fivefold increase in insurer capital September 8, 2026 Brown and Brown enters Scottish retail market September 8, 2026 $100B non-peak losses become ‘new normal’: Munich Re September 8, 2026 Facebook-f X-twitter Linkedin-in Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing. Never miss important news: Become a Business Insurance Online subscriber today Subscribe Now Information About Us Contact Advertise Privacy Policy Terms & Conditions Copyright 2026. BUSINESS INSURANCE HOLDINGS Member, Beacon International Group, Ltd.
Metadata (JSON)
{
"score": 13.6
}